Delivery Order SPE2DB20D2104-SPE2DB24FT38B

Award Date 4/2/24
Potential Completion Date 4/3/24
Potential Value $2.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,172.84, is for the supply of 4,567,278,594 units of Duloxetine HCL DR 60 MG capsules. The award is a Firm Fixed Price delivery order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a Delivery Order federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,268.15, is for the delivery of 4,567,363,922 units of Duloxetine HCL DR 60 mg capsules. The contract has a period of performance through February 25, 2025 and is a Firm Fixed Price contract type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Duloxetine HCl delayed-release 60 mg capsules in quantities of 90s. The contract has a completion date of January 26, 2024 and a potential value of $7,091.80. Amerisourcebergen Drug Corp, as a for-profit prime contractor, is providing these pharmaceutical products through its Corporate Office division located in Conshohocken, Pennsylvania. This order is...
This is a $1,543.10 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,567,571,538 units of duloxetine hydrochloride delayed-release 60 mg capsules, a medication used to treat conditions like depression and nerve pain. The contract has a period of performance through March 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract (SPE2DB20D1102|SPE2DB24FC6GH) by the Defense Logistics Agency (DLA) Troop Support Medical to provide 4,564,256,178 units of the prescription medication Duloxetine HCL DR 30 mg capsules. The $1,680.45 award has an ultimate completion date of April 15, 2024. This delivery order falls under Amerisourcebergen's $999,999,999.00 indefinite delivery contract with DLA, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,075.68 firm-fixed-price delivery order is for the supply of 4567655738 - Duloxetine HCL DR 40 MG Capsules, 30s. The contract has an ultimate completion date of March 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,460.42, is for the delivery of 4,567,793,444 units of the medication Duloxetine HCL DR 30 MG CAP. The contract is a firm fixed price delivery order with an ultimate completion date of April 4, 2025. AmerisourceBergen is the prime contractor, and there is no set-aside designation for this award....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of 4,564,530,932 capsules of Duloxetine Hydrochloride delayed-release 60 mg. The fixed-price contract has a ceiling value of $31,461.28 and a completion date of May 8, 2024. Amerisourcebergen, a major pharmaceutical distributor, does not have a small business set-aside designation for this award. The contract is issued under...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Duloxetine Hydrochloride delayed-release capsules. The contract has a ceiling value of $6,174.99 and an ultimate completion date of September 18, 2024. It is a firm fixed-price contract for the delivery of this prescription medication. The contract is not set aside for any specific business category. AmerisourceBergen,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,492.81, is for the supply of 4,567,028,341 units of Duloxetine HCL DR 60 MG capsules. This is an open competition contract, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FT38B
    Delivery Order

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,564,146 units of Duloxetine HCL DR 60 MG capsules. The order, valued at $2,208.48, has an ultimate completion date of April 3, 2024. AmerisourceBergen Drug Corp is the prime contractor on a single award indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this specific delivery order.

Generated 7/2/24, 2:34 PM